QA: Roivant Sciences Ltd in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001635088_2023_Roivant_Sciences_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001635088, Roivant Sciences Ltd

  xvar xval
0 AssetsCurrent 2,146,523,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 25,905,000
3 remainder_Assets 412,701,000
4 LiabilitiesCurrent 184,367,000
5 LiabilitiesNoncurrent 84,391,000
6 remainder_Liabilities 254,937,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 775,033,000
9 ResearchAndDevelopmentExpense 483,035,000
10 remainder_Expenses 156,270,000
11 remainder_Revenues 55,655,000
12 remainder_NetIncome 434,567,000
13 remainder_ComprehensiveNetIncome 76,463,000
  yvar yval
0 Assets 2,585,129,000
1 Liabilities 523,695,000
2 Expenses 1,414,338,000
3 Revenues 55,655,000
4 StockholdersEquity 2,061,434,000
5 NetIncome -924,116,000
6 ComprehensiveNetIncome -885,884,500
7 BaseVar 2,544,923,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.32
9 EconomicCapitalRatio 3.24

Edgar->Model Mapping

Feature Distribution

Change over Time